Medicamen Biotech standalone net profit declines 9.03% in the December 2024 quarter
Sales decline 6.92% to Rs 41.14 crore
Net profit of Medicamen Biotech declined 9.03% to Rs 2.52 crore in the quarter ended December 2024 as against Rs 2.77 crore during the previous quarter ended December 2023. Sales declined 6.92% to Rs 41.14 crore in the quarter ended December 2024 as against Rs 44.20 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales41.1444.20 -7 OPM %15.1712.67 -PBDT5.655.78 -2 PBT3.484.02 -13 NP2.522.77 -9Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content